GLI1 and neoplasm: Most importantly, arsenic trioxide (ATO), an anticancer drug that inhibits cell growth by targeting GLI1 [111,112], significantly inhibited the metastasis capability of EwS cells in vitro and reduced the tumor burden in 75% of stage III EwS patients [113].